>95% of CNS drugs fail in late-stage trials: Animals lack predictive power
Pharma needs human-relevant tools: Reduce cost, time, and attrition
What Drives Demand:
$2M–$4M and 2–3 years per IND study
~$1.2B cost per failed neurological asset
5–7-years with no translational insights
The First Commercial
‘Brain-on-Chip Interface’
Drug Discovery Platform
Organoids for Drug Discovery
Modeling Neural Circuits
We are integrating dense sensor array platforms for electrophysiology and impedance measurements with advanced cell culture and AI/ML-Driven Analysis Methods to Model the Brain.
Modeling Defined Neural Circuits
Modeling Neural Networks
Compared to Standard Technology
Cortical Spheroid Recording
Modeling Cell Growth Kinetics
Sensor Arrays Enable A New Paradigm of Cell-Based Screening for Applications in Drug Discovery.
Including Safety and Efficacy Evaluation, Based on Real-Time, High-Content Data.
Stay tuned, there is more to come…
If you are interested in learning more, please reach out via email or submit an
